PhaseBio Announces Topline Results From Phase 2b Trial for Bentracimab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to PhaseBio Announces Topline Results From Phase 2b Trial for Bentracimab
(NASDAQ: PHAS) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High $ 
Open $16.08    52 Week Low $ 
Day High $0.07    P/E N/A 
Day Low $0.07    EPS $ 
Volume 94,799